Cologuard has gone bilingual. The popular mail-in colorectal cancer screening test from Exact Sciences has a new campaign out ...

As it works to diversify its methods for catching early cases of colorectal cancer, Exact Sciences has put forward clinical ...

Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue-based ...

Exact’s test could compete with Guardant Health’s Shield blood test, which received approval from the Food and Drug ...

The results now are set to go alongside the company’s BLUE-C trial as part of an FDA submission for the cancer detecting ...

Exact Sciences (EXAS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Mark ...

Exact Sciences' management envisions blood-based testing as a viable alternative for those who decline both colonoscopy and Cologuard tests. Moreover, it is seen as a potential stepping stone for ...

Exact Sciences' management envisions blood-based testing as a viable alternative for those who decline both colonoscopy and Cologuard tests. Moreover, it is seen as a potential stepping stone for ...

Positive results of a colon cancer study conducted by Exact Sciences prompt the CEO of competitor Guardant Health to publicly ...